In patients with type 2 diabetes mellitus and insulin resistance, hyperinsulinemia as a result of endogenous hypersecretion may activate the IGF pathway, which stimulates cell proliferation and inhibit apoptosis [20]. Here, IGF1 is linked to hyperinsulinism.